| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 04/22/2003 | US6552018 As antitumor agents |
| 04/22/2003 | CA2253951C .delta.1,2bicyclo[4,4,0] functional dyes for contrast enhancement in optical imaging |
| 04/22/2003 | CA2239187C Inhibitors of farnesyl protein transferase |
| 04/22/2003 | CA2079646C Succinimide derivatives of 2,5-dimercapto-1,3,4-thiadiazole |
| 04/19/2003 | CA2361863A1 Composition and method for use of pyridinium derivatives in cosmetic and therapeutic applications |
| 04/17/2003 | WO2003031440A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists |
| 04/17/2003 | WO2003031437A1 Propylcarbamate derivatives as inhibitors of serine and cysteine proteases |
| 04/17/2003 | WO2003031436A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 04/17/2003 | WO2003031435A1 Pyrazole derivatives as glycine transporter inhibitors |
| 04/17/2003 | WO2003031428A1 Stereospecific process for the synthesis of 2-yl chroman derivatives |
| 04/17/2003 | WO2003031422A1 Novel benzothiazine derivatives, their preparation and use |
| 04/17/2003 | WO2003031420A1 Isothiazole derivatives |
| 04/17/2003 | WO2003031419A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes |
| 04/17/2003 | WO2003031414A1 Novel heterocyclic compound and anti-inflammatory agent |
| 04/17/2003 | WO2003031407A2 β-LACTAMYL VASOPRESSIN VlaANTAGONISTS |
| 04/17/2003 | WO2003031397A1 Acylsulfonamides as inhibitors of steroid sulfatase |
| 04/17/2003 | WO2003031376A1 Solid phase synthesis of substituted 1,5-benzodiazepine-2-one and 1,5-benzothiazepine-2-one |
| 04/17/2003 | WO2003030909A1 2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer |
| 04/17/2003 | WO2003030898A1 Modulators of ccr5 chemokine receptor activity |
| 04/17/2003 | WO2003013484A3 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents |
| 04/17/2003 | WO2003006454A3 Heterocyclic carboxamides and their use as fungicides |
| 04/17/2003 | WO2002069968A8 New use |
| 04/17/2003 | WO2001094341A9 Quinazoline derivatives for the treatment of tumours |
| 04/17/2003 | WO2001017965A3 Cyanopiperidines as pesticides |
| 04/17/2003 | US20030073852 Anticancer agents |
| 04/17/2003 | US20030073850 Incontinence; nasal congestion |
| 04/17/2003 | US20030073842 Psychological disorders; hypotensive agents |
| 04/17/2003 | US20030073836 Heteroarylcarboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions |
| 04/17/2003 | US20030073834 Purine compounds having PDE IV inhibitory activity and methods of synthesis |
| 04/17/2003 | US20030073732 Antiinflammatory agents |
| 04/17/2003 | US20030073726 Heterocyclic inhibitors of glycine transporter 2 |
| 04/17/2003 | US20030073718 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease |
| 04/17/2003 | US20030073706 Fused thiophone derivatives and drugs containing the same as the active ingredient |
| 04/17/2003 | US20030073687 Alzheimer's disease; anticancer agents; antidiabetic agents |
| 04/17/2003 | US20030073684 Respiratory system disorders; cardiovascular disorders; hemorrhage therapy |
| 04/17/2003 | US20030073682 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 04/17/2003 | US20030073677 Synergistic mixtures; anticancer agents; 2-(2 -methyl-4-thiazolyl)ethenyl)-4,17-dioxabicyclo(14.1.0)heptadecane-5,9 -dione or 4-aza-17-oxabicyclo(14.1.0) heptadecane-5,9-dione or 1-aza-13-cyclohexadecene-2,6-dione or 1-oxa-13-cyclohexadecene-2,6-dione derivatives |
| 04/17/2003 | US20030073669 N-heterocyclic derivatives as NOS inhibitors |
| 04/17/2003 | US20030073205 Production of polyketides |
| 04/17/2003 | US20030073047 Forms an azomethine dye upon a coupling reaction with an oxidized product of a developing agent |
| 04/17/2003 | CA2462862A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists |
| 04/17/2003 | CA2462860A1 Stereospecific process for the synthesis of 2-yl chroman derivatives |
| 04/17/2003 | CA2462000A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes |
| 04/17/2003 | CA2458456A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 04/17/2003 | CA2458453A1 Acylsulfonamides as inhibitors of steroid sulfatase |
| 04/17/2003 | CA2458388A1 Novel benzothiazine derivatives, their preparation and use |
| 04/16/2003 | EP1302468A1 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
| 04/16/2003 | EP1302467A2 Process for the preparation of substituted thiazoline derivatives and their intermediate |
| 04/16/2003 | EP1302466A1 Benzoxazole compound, process for producing the same, and herbicide |
| 04/16/2003 | EP1302463A1 Medicine comprising dicyanopyridine derivative |
| 04/16/2003 | EP1302462A1 Sulfone derivatives, process for their production and use thereof |
| 04/16/2003 | EP1302461A1 Tnf-alpha production inhibitors |
| 04/16/2003 | EP1301487A2 Viral polymerase inhibitors |
| 04/16/2003 | EP1301484A2 Capsaicin receptor ligands |
| 04/16/2003 | EP1301483A1 1-aryl-4-alkyl halide-2(1h)-pyridones and their use as herbicides |
| 04/16/2003 | EP1301482A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 04/16/2003 | EP1301481A1 Pyrrole derivatives for treating aids |
| 04/16/2003 | EP1301480A1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 04/16/2003 | EP1181017B1 Metalloprotease inhibitors |
| 04/16/2003 | EP0880508B1 Quinazoline derivatives as vegf inhibitors |
| 04/16/2003 | CN1411460A Substituted homopiperidinyl benzimidazole analogues as fundic relaxants |
| 04/16/2003 | CN1411457A Substituted pyrroles |
| 04/16/2003 | CN1411456A Chemokine receptor binding heterocyclic compounds |
| 04/16/2003 | CN1411445A Method for preparing 3-hydroxypicolinic acid derivatives |
| 04/16/2003 | CN1411379A Preventives or remedies for arrhythmia |
| 04/16/2003 | CN1105718C Improved method for producing thiazolidinediones, and new thiazolidinediones |
| 04/16/2003 | CN1105707C Pyrazole derivative |
| 04/16/2003 | CN1105706C Cyclic amidino agents useful as nitric oxide synthase inhibitors |
| 04/15/2003 | US6548667 For prevention and treatment of diseases caused by overexpression and overactivation of matrix metalloproteinase |
| 04/15/2003 | US6548666 Tricyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them |
| 04/15/2003 | US6548638 Peptoid and nonpeptoid containing α-keto oxadiazoles as serine protease inhibitors |
| 04/15/2003 | US6548526 Isothiazole derivatives useful as anticancer agents |
| 04/15/2003 | US6548516 (NMDA=N-methyl-D-aspartate); where the heteroaryl is 3H-benzoxazol-2-one, 3H-benzothiazol-2-one, 3H-benzimidazol-2-one or indolin-2-one; excitatory amino acid antagonists for combating neurodegenerative disorders |
| 04/15/2003 | US6548512 Nitrogen containing heteroaromatics as factor Xa inhibitors |
| 04/15/2003 | US6548499 Substituted quinoxaline derivatives as interleukin-8 receptor antagonists |
| 04/15/2003 | US6548495 Dihydro-benzo [B] [1,4] diazepin-2-one derivatives |
| 04/15/2003 | US6548481 A salt form of a dipeptide compound formed from an amino acid and a thiazolidine or pyrrolidine group, and the salts are selected from acetates, tartrates, fumarates, succinates, phosphates and sulfates |
| 04/15/2003 | US6548451 Use of derivatives of 2-oxopyrrole as crop protection agents and novel 2-oxopyrroles |
| 04/15/2003 | CA2274338C Ziprasidone formulations |
| 04/15/2003 | CA2169737C Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives |
| 04/15/2003 | CA2099588C Prevention of synovial adhesions |
| 04/15/2003 | CA2037975C 5-hydroxy-2,3-dihydrobenzofuran analogs as leukotriene biosynthesis inhibitors |
| 04/10/2003 | WO2003029251A1 Novel process for the synthesis of thiazolidinedione derivatives |
| 04/10/2003 | WO2003029250A1 Benzisothiazolyl-substituted aminomethyl chromanes for treating diseases of the central nervous system |
| 04/10/2003 | WO2003029249A1 Thiazolyl substituted aminopyrimidines as plant protection agents |
| 04/10/2003 | WO2003029248A1 N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl) -n-phenylamines as antiproliferative compounds |
| 04/10/2003 | WO2003029238A1 Chroman derivatives as 5-hydroxytryptamine-6 ligands |
| 04/10/2003 | WO2003029215A1 4[piperidin-4-yliden-(3-carbamoylphenyl)methyl] benzamide derivatives and their use for the treatment of pain, spinal injuries or gastrointestinal disorders |
| 04/10/2003 | WO2003029210A2 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 04/10/2003 | WO2003029195A1 Intermediates for epothilone derivative and process for producing these |
| 04/10/2003 | WO2003028729A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | WO2003028720A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 04/10/2003 | WO2003028719A1 Substituted 2,5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases |
| 04/10/2003 | WO2003028650A2 Benzimidazolidinone derivatives as muscarinic agents |
| 04/10/2003 | WO2003028641A2 Mch receptor antagonists |
| 04/10/2003 | WO2003028458A1 N-thio-nicotinamide derivatives and related compounds for use as pesticides |
| 04/10/2003 | WO2003004493A8 Novel compounds, their preparation and use |
| 04/10/2003 | WO2002094203A3 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 04/10/2003 | WO2002078596A3 Novel dyeing composition for dyeing keratinous fibres comprising a particular dicationic diazo dye |
| 04/10/2003 | WO2002070540A3 Peptide deformylase inhibitors |